Dentsply Sirona Faces Legal Action Over Misleading Statements
Scott+Scott Attorneys at Law LLP, a renowned law firm dedicated to protecting shareholder rights, has recently filed a significant securities class action lawsuit against Dentsply Sirona, Inc. (NASDAQ: XRAY). This lawsuit is taking place in the United States District Court for the Southern District of New York and names both current and former officers and directors of the company as Defendants.
Overview of the Class Action Lawsuit
The lawsuit centers on claims made under §§10(b) and 20(a) of the Securities Exchange Act of 1934, including U.S. Securities and Exchange Commission Rule 10b-5. This action is on behalf of all individuals who purchased or acquired Dentsply securities during a specified Class Period from February 28, 2022, to November 6, 2024. The allegations contend that during this period, Dentsply and its leadership made misleading statements or omitted critical information regarding the company's operations and financial health.
Details of the Allegations
It is alleged that Defendants failed to inform investors about several key issues affecting the company. The lawsuit claims Dentsply targeted vulnerable, low-income individuals with dental issues that did not qualify for standard aligner treatments. Moreover, it is contended that the company sold its Byte aligners, a direct-to-consumer orthodontic solution, to patients who were unsuitable for such treatment, leading to severe complications and injuries.
Impact of Misleading Information on Investors
The repercussions of these undisclosed issues became evident when the truth began to surface in the market. The company's stock price witnessed substantial declines as investors reacted to the negative revelations. Notably, on a significant day—November 7, 2024—Dentsply reported a considerable downward revision of its revenue outlook for the year, attributing it to various market pressures and issues related to its DTC model. Consequently, the stock plummeted, with a drop of over 28%, closing at $17.26 per share on heavy trading volume.
Steps for Affected Investors
Dentsply shareholders who suffered losses during the class period may be able to take action. If you purchased Dentsply common stock and were affected, you could potentially seek to be appointed as a lead plaintiff in this case. This role represents individuals who did not directly participate in the litigations but have a stake in the lawsuit’s outcome.
Lead Plaintiff Deadline
If you are looking to apply for lead plaintiff status, it is critical to file your motion with the U.S. District Court for the Southern District of New York by a specified deadline. While becoming a lead plaintiff can amplify your voice, it is not a prerequisite for obtaining a share of any settlement should there be a recovery for the class.
What to Do Next
Concerned investors are encouraged to consult with legal professionals to understand their rights concerning this lawsuit and the possibility of serving as lead plaintiff. Engaging an attorney can offer clarity on how best to proceed, considering the complexities involved in such securities litigation.
About Scott+Scott Attorneys at Law LLP
Scott+Scott is well-established in the realm of securities litigation, with a distinguished track record in handling significant securities, antitrust, and consumer rights actions across the United States. With offices in major cities like New York and London, the firm represents a diverse clientele, including pension funds, foundations, and individual investors worldwide.
Frequently Asked Questions
What is the basis of the lawsuit against Dentsply Sirona?
The lawsuit accuses Dentsply's leadership of making misleading statements regarding the company's financial condition and business practices impacting investors.
Who can participate in the class action?
Anyone who purchased shares of Dentsply during the defined Class Period and suffered financial harm may be eligible to participate.
What are the key dates to remember in this case?
Key dates include the lead plaintiff deadline, which is set for January 27, 2025.
How can I become a lead plaintiff?
To become a lead plaintiff, you must file a motion with the court by the stated deadline, indicating your interest in representing the class.
What should I do if I’m affected?
It’s advisable to consult with an attorney to discuss your options and rights regarding the ongoing class action against Dentsply.
